ADVISORY/Leading Advocacy And Medical Organizations Launch New Initiative To Help New York Residents With Diabetes Aim For, Believe In, And Achieve Optimal Blood Sugar Control.News/Assignment Editors & Health/Medical Writers ADVISORY...for Thursday Thursday: see week. (Nov. 14) --(BUSINESS WIRE)
WHAT: Today in New York, and in 16 major cities nationwide, a new
program called Aim. Believe. Achieve: The Diabetes A1C
Initiative (TM) will educate people about A1C and help them
understand that they can achieve a target of less than 7%.
Representatives from leading advocacy and medical
organizations join key policymakers to issue a call to
action, urging New York residents to help the more than
748,000 people in New York living with type 2 diabetes to
achieve and maintain target blood sugar levels (an A1C<7%).
WHO: New York City Health and Hospitals Corporation President and
Chief Executive Officer Benjamin K. Chu, M.D., MPH, will be
joined by:
- Jerome Tolbert, M.D., Ph.D., Chair, NYC Leadership
Council, American Diabetes Association
- Pat Linekin, President, Metro New York Association of
Diabetes Educators
- Local area diabetes advocates: Ken Feldman (area resident
with diabetes) and Jan Seley (certified diabetes educator)
WHEN/WHERE: 2:00 p.m., Thursday, Nov. 14th, World Diabetes Day,
Bellevue Hospital Center Rose Room (462 First Avenue
at 27th Street) in Manhattan.
Other proclamation events will be occurring
simultaneously in Atlanta, Baltimore, Boston,
Chicago, Dallas, Denver, Detroit, Houston, Los
Angeles, Madison, Miami, Minneapolis, Philadelphia,
San Francisco, and Seattle. A national proclamation
event will also take place in Washington, D.C.
Editor Note A1C A1C abbr. airman first class (also known as HbA1C or glycated hemoglobin hemoglobin (hē`məglō'bĭn), respiratory protein found in the red blood cells (erythrocytes) of all vertebrates and some invertebrates. ) is the standard for measuring blood sugar, or glucose, control over a two-month period. A target of less than 7% is recommended by the American Diabetes Association The American Diabetes Association, or the ADA, is an American health organization providing diabetes research, information and advocacy. Founded in 1940, the American Diabetes Association conducts programs in all 50 states and the District of Columbia, reaching hundreds of for optimal blood sugar control. Yet despite the availability of treatments that can effectively help people reach this target, more than half of the 11 million Americans who have already been diagnosed with the disease are not achieving this goal. As a result, millions of people may be at risk for serious complications associated with diabetes such as heart disease, stroke, blindness, kidney damage kidney damage Kidney injury Nephrology A structural or functional compromise in renal function due to external–eg, athletic, occupational, or other trauma, resulting in bruising or hemorrhage, which can be profuse and life threatening Etiology Vascular , and amputation amputation (ăm'pyətā`shən), removal of all or part of a limb or other body part. Although amputation has been practiced for centuries, the development of sophisticated techniques for treatment and prevention of infection has greatly . This initiative is being sponsored by Aventis Aventis Is a pharmaceutical and lab assay testing company. It was formed in 1999 when Rhône-Poulenc S.A. merged with Hoechst AG. The merged company was based in Strasbourg, France. Sanofi-Aventis was formed in 2004 when Sanofi-Synthélabo purchased Aventis. Pharmaceuticals. For more information on type 2 diabetes type 2 diabetes n. See diabetes mellitus. , Aim. Believe. Achieve: The Diabetes A1C Initiative(TM), or A1C testing visit www.diabeteswatch.com/A1C or call 1-800-922-5324. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion